ABSTRACT
Antecedentes: en los últimos 30 años, la creación de nuevos programas de trasplante hepático ha respondido a la difusión de esta terapéutica para el tratamiento de la insuficiencia hepática irreversible. Objetivo: describir la organización y el desarrollo de un Programa de Trasplante Hepático en una institución sanatorial de Mar del Plata, y sus resultados iniciales. Material y método: se constituyó un equipo profesional con especialistas en trasplante hepático en las disciplinas: cirugía, anestesia, terapia intensiva, hepatología, instrumentación, enfermería, hemoterapia y hematología, que se acreditaron ante los organismos fiscalizadores. La institución fue adecuada edilicia y tecnológicamente para este tipo de emprendimiento. Se trasplantaron con donante cadavérico completo 32 pacientes de localidades vecinas (55%) y de Mar del Plata (45%). Las etiologías más frecuentes de la cirrosis fueron hepatitis C y abuso de alcohol. Resultados: la mortalidad operatoria fue 12,5%. La supervivencia actuarial de los trasplantados fue 75% a los 55 meses. Seis pacientes desarrollaron de inmediato estenosis biliares , que fueron tratadas satisfactoriamente en forma conservadora. Conclusiones: el Programa de Trasplante Hepático de Mar del Plata asiste al área geográfica del sudeste de la provincia de Buenos Aires. Los resultados iniciales alcanzados encuadran en lo esperable para los estándares actuales en la materia.
Background: Over the past 30 years, new liver transplant programs have emerged as a response to the increasing use of this therapy to treat irreversible liver failure. Objective: the aim of this presentation is to describe the organization, development and initial results of a Liver Transplant Program in Mar del Plata. Material and methods: A team of professionals trained in liver transplantation was created, with specialists in surgery, anesthesiology, intensive care, hepatology, hemotherapy, hematology, and registered nurses and nurse scrubs granted by regulatory agencies. Building alterations, and technical and adaptations were implemented. Thirtytwo transplantations were performed with complete cadaveric donor in patients from neighboring localities (55%) and from Mar del Plata (45%). The most common etiologies of cirrhosis were chronic hepatitis C virus infection and alcohol abuse. Results: Operative mortality was 12.5%. Actuarial survival at 55 months of the 32 recipients was 75%. Six bile drug strictures late postoperative period which were treated successfully trated with a conservative approach Conclusions: the Liver Transplant Program in Mar del Plata provides care to the geographic area of the southeast of the province of Buenos Aires. The initial results are consistent with those expected for the current standards in liver transplantation.
ABSTRACT
We reporte the initial results of open stent-grafting (OSG) applied with a Matsui-Kitamura (MK) stent in the treatment of thoracic aortic aneurysm (TAA). From August 2005 to March 2011, OSG for TAA was applied in 35 cases (male/female, 29/6, 58∼86 years old, mean age 71). During deep hypothermic circulatory arrest with antegrade selective cerebral perfusion, the stent graft was delivered through the transected proximal aortic arch, followed by arch replacement with a 4-branched prosthesis. Concomitant procedures included 1 coronary artery bypass graft, 1 mitral valve replacement and 2 pacemaker implantations. Operative mortality within 30 days was 5.7% (respiratory failure in 1 and ischemic enteritis in 1). There was 1 in-hospital death due to brain stem infarction. Perioperative morbidity included 2 (5.7%) stroke, 5 (14.3%) spinal cord injuries (paraplegia in 1, paraparesis in 1 and transient paraparesis in 3) , and 1 (2.9%) temporary hemodialysis. Ten patients (28.6%) were intubated for more than 72 h. There was no complication with the graft-related incident. These initial results suggested the OSG method applied with a MK stent is a useful surgical procedure for the treatment of TAA.
ABSTRACT
BACKGROUND: Transluminal balloon coronary angioplasty is one of the most widely used therapeutic procedures in the treatment of patients with coronary artery disease. However, restenosis remains a major limitation of percutaneous coronary angioplasty despite extensive efforts to prevent recurrence. We examined the immediate and long-term results of 516 patients (617 lesions) who underwent coronary angioplasty to evaluate the initial success rate, complications, restenosis rate, and the factors affecting initial success and restenosis. METHODS: The coronary angioplasty of 516 patients(M/F : 388/128, mean age : 57 years), 671 lesions was done with conventional technique and follow-up coronary angiogram was obtained 4 to 6 months after angioplasty in 168 patients. The angiographic restenosis was defined as >50% luminal narrowing in a previously dilated lesion, and the clinical restenosis defined as the recurrence of typical angina and/or positive tests of treadmill test, or thallium scintigraphy during follow-up period. RESULTS: 1) The coronary angioplasty was successful in 459 of 516 patients(89%), 604 of 671 lesions(90%). The success rate was significantly lower in subgroups with type C lesion(52.2%, p<0.001), right coronary artery (83.7%, p<0.05) and <3.0mm of size of lesion(81.4%, p<0.001). 2) The procedural complications were as follows : intimal dissection in 143 lesions(21.3%) including acute closure in 9 lesions(1.3%), emergency bypass surgery in 6 patients(1.2%), myocardial infarction in 9 patients(1.7%), rupture of coronary artery in 2 patients, air embolism in 1 patient, and death in 1 patient(0.19%). 3) The causes of the procedural failure(n=57 patients) included guidewire passage failure in 27, balloon passage failure in 4, catheter engagement failure in 1, acute closure in 7, coronary artery rupture in 2, and suboptimal result in 16 patients. 4) Clinical follow-up was obtained in 455 patients for a mean follow-up duration of 13.2months and clinical restenosis rate was 31%(141/455). The repeat coronary angiogram was performed in 168 patients(209 lesions) for a mean follow up duration 5.4month and demonstrated 48%(100/209) angiographically restenosis rate. The clinical restenosis rate was significantly lower in subgroups with <10% of residual stenosis(18.9%, p<0.05), left circumflex coronary artery(18.5%, p<0.05). 5) The restenosis following angioplasty(n=100 lesions) was treated with repeated PTCA in 57, Stent(Palmaz-Schatz) in 6, DCA in 3, elective CABG in 9, and medication in 25. 6) During the clinical follow-up, there were nonfatal myocardial infarction in 4 patients. CONCLUSION: 1) The coronary angioplasty is an effective treatment for revascularization that has a high success rate, low incidence of complications and excellent long-term survival. 2) The restenosis rate was affected by residual stenosis which suggests that the implication of minimal residual stenosis is the most important determining factor to reduce the restenosis rate after angioplasty.